Updates

Kainos - Headcount +26% to 1470 : best proxy for growth

June 2019

Investing in shares may lose you all or some of your money. Past performance is no indication of future performance. Some of the shares recommended here may be small company shares, which can be relatively illiquid and hard to trade and this makes such shares more risky than other investments.

Kainos is building a reputation for being consistently boring - the kind of boring I like, with all growth being organic. Latest full year results showed sales grew 56% to £151.3m, adjusted pretax profit by 52% to £23.3m and eps by 48% to 15.4p. And the profit is pouring out in cash with net cash up 47% to £42.5m.Headcount, which is the biggest proxy for future growth, was up 26% to 1,470. Sales orders in the year totalled £171m, up a third on the year. Included in this figure is £18.4m of SaaS product sales orders, an increase of 38%. This resulted in the overall contracted backlog growing by 10% to £122m. International revenues were up 44% to £29m.The picture is similar to pre ...

To access our archive of articles and to receive current issues you need to subscribe.

Subscribe now

Already a subscriber? Login

Altitude

Watkin Jones

Kainos (October 2020)

Kainos -Huge beat on forecasts and special dividend (September 2020)

Kainos - Helping government deal with COVID-19 fallout (May 2020)

Kainos - Gain to date: 213% (December 2019)

Kainos - Employee number reaches 1,300 (January 2019)

Kainos (October 2018)

Kainos - All going well for government digitalisation (May 2018)

Kainos (January 2018)

Kainos (October 2017)

Kainos (July 2017)

Kainos (May 2017)

Kainos - Government digital side trading strongly (October 2016)

Kainos (July 2016)

Kainos - 88.7% of sales repeat in nature (May 2016)

Kainos - Evolve document management software going gangbusters (April 2016)

Kainos - Order backlog +54% to Â£56.7m (December 2015)

Kainos (September 2015)

Kainos - 88% sales repeat in nature (August 2015)

With small companies there is an above average degree of risk compared to buying blue chips. Please be aware that we have not assessed the suitability of any of these investments for you. The newsletter simply states a personal view and diarises the editor’s investment decisions. Please speak to your stockbroker or other qualified individual to ascertain whether any of these companies mentioned would form useful additions to your own portfolios. Past performance is no indication of future success.

All material on this website is protected by copyright. You may use Information retrieved from the www.scsw.co.uk website for your own personal non-commercial use which means that you may not sell or copy this information to any third party without prior written consent. ISSN 1358-183X